Jenna Kim, MD
Ophthalmic Plastic and Reconstructive Surgery · Suwanee, GANPI 1184037129
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,647 of the $1,855 with a category attached, or 88.8%. 14 manufacturers reported payments, led by Amgen at 42.0% of the total. Reporting peaked in 2022 at $504 and has fallen 63.2% since, to $185 in 2025.
Across 57 payments — averaging $32.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$778
- AbbVie$490
- Glaukos Corporation$137
- Alcon$91
- Organogenesis Inc.$73
- Mallinckrodt Hospital Products Inc.$65
- plus $219 from 8 others
What the payments were for
- Consulting fees$503%
- Food & beverage$1,64789%
- Education$1589%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 21 | $778 |
| AbbVie(2 entities) | 17 | $490 |
| Glaukos Corporation | 1 | $137 |
| Alcon | 5 | $91 |
| Organogenesis Inc. | 1 | $73 |
| Mallinckrodt Hospital Products Inc. | 3 | $65 |
| Medtronic | 1 | $50 |
| Acelrx Pharmaceuticals, Inc. | 1 | $36 |
| Aerie Pharmaceuticals, Inc. | 2 | $31 |
| Merz Pharmaceuticals, LLC | 1 | $28 |
| Harrow Eye, LLC | 1 | $25 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $17 |
| Agiliti Surgical, Inc. | 1 | $16 |
| Kala Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$374
- CE-marked KXLA system$137
How this compares
Too few ophthalmic plastic and reconstructive surgery providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErythromycinErythromycin Base | 280 | $2,813 |
| Tramadol Hcl | 13 | $19 |
Paid to pharmacies, not to this prescriber.
Other ophthalmic plastic and reconstructive surgery in Suwanee
- Juan ServatSuwanee$320
- Eric BaylinSuwanee$186
- Brent HayekGainesville$191K
- Daniel HwangAtlanta$105K
- Julia KangJohns Creek$71K
- Adam de la GarzaAtlanta$17K
- Pooja MallyDuluth$4K
- Michael NeimkinAtlanta$2K
- Zhenyang ZhaoAtlanta$742
- Adam WeberKennesaw$706
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.